Mark Berger
2021
In 2021, Mark Berger earned a total compensation of $584.4K as Former Chief Medical Officer at Actinium Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
| Option Awards | $279,395 |
|---|---|
| Salary | $304,962 |
| Total | $584,357 |
Berger received $305K in salary, accounting for 52% of the total pay in 2021.
Berger also received $279.4K in option awards.
Rankings
In 2021, Mark Berger's compensation ranked 10,373rd out of 12,406 executives tracked by ExecPay. In other words, Berger earned more than 16.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,373 out of 12,406 | 16th |
Division Manufacturing | 4,588 out of 5,492 | 17th |
Major group Chemicals And Allied Products | 2,055 out of 2,368 | 13th |
Industry group Drugs | 1,823 out of 2,089 | 13th |
Industry Pharmaceutical Preparations | 1,349 out of 1,536 | 12th |
Source: SEC filing on November 21, 2022.
Berger's colleagues
We found three more compensation records of executives who worked with Mark Berger at Actinium Pharmaceuticals in 2021.